FIT 2 SIT - Are Metabolic Responses to Sitting/Light Breaks Mediated by Fitness?
FIT2SIT
The Impact of Cardio-respiratory Fitness on an Individual's Metabolic Response to Sitting and Light Activity Breaks
2 other identifiers
interventional
34
1 country
1
Brief Summary
The purpose of this study is to determine whether an individuals cardio-respiratory fitness level can protect them from the negative metabolic impacts of prolonged sitting time. Overall, it is hypothesised that in individuals with high fitness, the unfavourable effect of prolonged sitting (build up of sugar, fat and insulin in the blood following a meal) will not be as substantial, nor will light activity breaks be as advantageous, compared to individuals with lower fitness as they have a smaller scope for metabolic improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes
Started Oct 2014
Shorter than P25 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 6, 2015
CompletedFirst Posted
Study publicly available on registry
July 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedJanuary 30, 2020
October 1, 2014
1 year
July 6, 2015
January 29, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Blood glucose Area Under the Curve (AUC)
Blood glucose AUC refers to the spike of an individuals blood sugar following a meal, the aim of which is to reduce the spike and consequently reduce the area under the curve.
Assessed via 11 blood samples throughout each treatment condition throughout the 7.5 hour period
Secondary Outcomes (3)
Blood Triglyceride AUC
Assessed via 11 blood samples throughout each treatment condition throughout the 7.5 hour period
Insulin AUC
Assessed via 11 blood samples throughout each treatment condition throughout the 7.5 hour period
Blood Pressure
Taken immediately before each blood sample is taken.
Study Arms (2)
Prolonged sitting
EXPERIMENTALLight activity breaks
ACTIVE COMPARATORInterventions
Condition A is referred to as the 'sitting' condition. Here participants will remain seated throughout the whole of the 7 ½ hour test period (8am - 3:30pm). On arrival, participants will have a cannula (a small tube that allows us to take blood) inserted into their arm; this will stay in the arm and allow us to take regular blood samples throughout the day. Blood samples and blood pressure will be taken at 30, 60, 120 and 180 minutes after breakfast. We will then provide a lunch meal and will continue taking blood samples and blood pressure at 30, 60, 120, 180 and 210 minutes after this lunch meal. In total, we will take 11 blood samples over the 7 ½ hour testing period.
Condition B is the 'light activity breaks' condition. Participants will go through exactly the same process as condition A but will also be asked to do 5 minute bouts of slow walking on a treadmill every 30 minutes following breakfast and lunch. In total they will do 12 five minute walks on the treadmill throughout the 7 ½ hour test period (60 minutes of walking in total). In total, we will take 11 blood samples on the day.
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study
- Body Mass Index: 20 - 30 kg/m2
- Male and Female
- Aged: ≥ 25 to ≤ 55 years of age.
- Occupation: Work full-time in a predominantly sedentary occupation.
You may not qualify if:
- The participant may not enter the study if ANY of the following apply:
- Aged \<25 or \>55 years of age.
- Physical condition which limits full participation in the study
- Active psychotic illness or other significant illness which, in the view of the investigators, would prevent full participation
- Inability to communicate in spoken English
- Steroid use
- Known Type 2 Diabetes
- Pre-existing Cardio-vascular Disease (disease of the heart or blood vessels at present or in the past) For example: Heart attack, Stroke or Angina.
- Pregnancy
- Smoker
- Terminal illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leicester Diabetes Centre, Leicester General Hospital
Leicester, Leicestershire, LE5 4PW, United Kingdom
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Yates, PhD
University of Leicester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2015
First Posted
July 9, 2015
Study Start
October 1, 2014
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
January 30, 2020
Record last verified: 2014-10